Crisnatol Mesilate

N/A

Report date: 2022/05/17 17:49:30
NME

Base Information

Drug NameCrisnatol Mesilate
Drug Alias Name甲磺酸克立那托Crisnatolum克立那托BW-77OU82BW-770 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG